Stephen Mayo

Director · 4 filings · Latest: Jun 18, 2026

Allogene Therapeutics, Inc.

Merck & Co., Inc.

Sarepta Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SRPT	Stephen Mayo	Director	Mar 12, 2026	Sale	$17.02	7,239	$123.2K	1,765	Mar 14 12:03 AM
SRPT	STEPHEN MAYO	—	Mar 12, 2026	Proposed Sale	$17.02	7,239	$123.2K	—	Mar 12 8:27 PM